One dose of experimental drug nearly wipes out stealthy cholesterol in 'remarkable' trial – NBC News
Business News
- One dose of experimental drug nearly wipes out stealthy cholesterol in ‘remarkable’ trial NBC News
- Eli Lilly Drug Reduces Mysterious Lp(a) Particle Involved in Heart Attack Risk The New York Times
- Lilly’s lepodisiran reduced levels of genetically inherited heart disease risk factor, lipoprotein(a), by nearly 94% from baseline at the highest tested dose in adults with elevated levels Investors | Eli Lilly and Company
- Experimental Lilly drug cuts genetic heart disease risk factor by 94% in trial Reuters.com
- Experimental Gene-Silencing Drug Produces Long-Duration Reduction in Lipoprotein(a), an Important Heart Disease Risk Factor Cleveland Clinic Newsroom
Source: Business News